SIRIUSPOINT LTD (SPNT) Stock Fundamental Analysis

NYSE:SPNT • BMG8192H1060

21.14 USD
-0.12 (-0.56%)
At close: Feb 27, 2026
21.14 USD
0 (0%)
After Hours: 2/27/2026, 8:04:00 PM
Fundamental Rating

3

SPNT gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 150 industry peers in the Insurance industry. SPNT has a bad profitability rating. Also its financial health evaluation is rather negative. SPNT has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • In the past year SPNT was profitable.
  • SPNT had a positive operating cash flow in the past year.
  • SPNT had positive earnings in 4 of the past 5 years.
  • In the past 5 years SPNT always reported a positive cash flow from operatings.
SPNT Yearly Net Income VS EBIT VS OCF VS FCFSPNT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M 400M -400M

1.2 Ratios

  • SPNT has a Return On Assets (1.49%) which is comparable to the rest of the industry.
  • The Return On Equity of SPNT (8.39%) is worse than 60.67% of its industry peers.
  • SPNT has a Return On Invested Capital of 2.63%. This is comparable to the rest of the industry: SPNT outperforms 55.33% of its industry peers.
Industry RankSector Rank
ROA 1.49%
ROE 8.39%
ROIC 2.63%
ROA(3y)2.52%
ROA(5y)0.87%
ROE(3y)13.51%
ROE(5y)4.58%
ROIC(3y)N/A
ROIC(5y)N/A
SPNT Yearly ROA, ROE, ROICSPNT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 -20

1.3 Margins

  • SPNT's Profit Margin of 6.49% is in line compared to the rest of the industry. SPNT outperforms 40.67% of its industry peers.
  • In the last couple of years the Profit Margin of SPNT has declined.
  • SPNT's Operating Margin of 13.29% is in line compared to the rest of the industry. SPNT outperforms 56.00% of its industry peers.
  • SPNT's Operating Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 13.29%
PM (TTM) 6.49%
GM N/A
OM growth 3YN/A
OM growth 5Y0.56%
PM growth 3YN/A
PM growth 5Y-2.86%
GM growth 3YN/A
GM growth 5YN/A
SPNT Yearly Profit, Operating, Gross MarginsSPNT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 -40 -60 -80

2

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so SPNT is destroying value.
  • Compared to 1 year ago, SPNT has more shares outstanding
  • SPNT has more shares outstanding than it did 5 years ago.
  • The debt/assets ratio for SPNT is higher compared to a year ago.
SPNT Yearly Shares OutstandingSPNT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
SPNT Yearly Total Debt VS Total AssetsSPNT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

2.2 Solvency

  • SPNT has a debt to FCF ratio of 3.21. This is a good value and a sign of high solvency as SPNT would need 3.21 years to pay back of all of its debts.
  • SPNT has a Debt to FCF ratio (3.21) which is comparable to the rest of the industry.
  • SPNT has a Debt/Equity ratio of 0.31. This is a healthy value indicating a solid balance between debt and equity.
  • SPNT has a Debt to Equity ratio (0.31) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF 3.21
Altman-Z N/A
ROIC/WACC0.29
WACC8.92%
SPNT Yearly LT Debt VS Equity VS FCFSPNT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B 2B 2.5B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
SPNT Yearly Current Assets VS Current LiabilitesSPNT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

6

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 284.38% over the past year.
  • SPNT shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 19.73% yearly.
  • Looking at the last year, SPNT shows a quite strong growth in Revenue. The Revenue has grown by 14.72% in the last year.
  • The Revenue has been growing by 29.21% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)284.38%
EPS 3YN/A
EPS 5Y19.73%
EPS Q2Q%1615.38%
Revenue 1Y (TTM)14.72%
Revenue growth 3Y15.03%
Revenue growth 5Y29.21%
Sales Q2Q%8.91%

3.2 Future

  • The Earnings Per Share is expected to decrease by -5.53% on average over the next years.
  • SPNT is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 10.43% yearly.
EPS Next Y-33.11%
EPS Next 2Y-13.85%
EPS Next 3Y-5.53%
EPS Next 5YN/A
Revenue Next Year6.95%
Revenue Next 2Y6.64%
Revenue Next 3Y10.43%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
SPNT Yearly Revenue VS EstimatesSPNT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B
SPNT Yearly EPS VS EstimatesSPNT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 2 -2

5

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 5.73, the valuation of SPNT can be described as very cheap.
  • Based on the Price/Earnings ratio, SPNT is valued cheaply inside the industry as 82.67% of the companies are valued more expensively.
  • SPNT is valuated cheaply when we compare the Price/Earnings ratio to 27.10, which is the current average of the S&P500 Index.
  • Based on the Price/Forward Earnings ratio of 8.56, the valuation of SPNT can be described as reasonable.
  • 66.00% of the companies in the same industry are more expensive than SPNT, based on the Price/Forward Earnings ratio.
  • SPNT's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 28.06.
Industry RankSector Rank
PE 5.73
Fwd PE 8.56
SPNT Price Earnings VS Forward Price EarningsSPNT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, SPNT is valued a bit cheaper than the industry average as 70.67% of the companies are valued more expensively.
  • The rest of the industry has a similar Price/Free Cash Flow ratio as SPNT.
Industry RankSector Rank
P/FCF 11.6
EV/EBITDA 6.6
SPNT Per share dataSPNT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

  • A cheap valuation may be justified as SPNT's earnings are expected to decrease with -5.53% in the coming years.
PEG (NY)N/A
PEG (5Y)0.29
EPS Next 2Y-13.85%
EPS Next 3Y-5.53%

0

5. Dividend

5.1 Amount

  • No dividends for SPNT!.
Industry RankSector Rank
Dividend Yield 0%

SIRIUSPOINT LTD

NYSE:SPNT (2/27/2026, 8:04:00 PM)

After market: 21.14 0 (0%)

21.14

-0.12 (-0.56%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)02-18
Earnings (Next)05-04
Inst Owners87.28%
Inst Owner Change0.66%
Ins Owners1.59%
Ins Owner Change-6.84%
Market Cap2.47B
Revenue(TTM)3.19B
Net Income(TTM)185.50M
Analysts80
Price Target23.97 (13.39%)
Short Float %1.7%
Short Ratio2.58
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0.11
Dividend Growth(5Y)N/A
DP8.63%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)13.28%
Min EPS beat(2)-13.77%
Max EPS beat(2)40.33%
EPS beat(4)2
Avg EPS beat(4)0.89%
Min EPS beat(4)-131.86%
Max EPS beat(4)108.87%
EPS beat(8)5
Avg EPS beat(8)14.3%
EPS beat(12)8
Avg EPS beat(12)37.79%
EPS beat(16)9
Avg EPS beat(16)12%
Revenue beat(2)1
Avg Revenue beat(2)1.95%
Min Revenue beat(2)-9.34%
Max Revenue beat(2)13.24%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)8.91%
EPS NQ rev (3m)5.77%
EPS NY rev (1m)-3.96%
EPS NY rev (3m)3.36%
Revenue NQ rev (1m)0.19%
Revenue NQ rev (3m)4.41%
Revenue NY rev (1m)1.46%
Revenue NY rev (3m)1.42%
Valuation
Industry RankSector Rank
PE 5.73
Fwd PE 8.56
P/S 0.86
P/FCF 11.6
P/OCF 11.6
P/B 1.12
P/tB 1.18
EV/EBITDA 6.6
EPS(TTM)3.69
EY17.46%
EPS(NY)2.47
Fwd EY11.68%
FCF(TTM)1.82
FCFY8.62%
OCF(TTM)1.82
OCFY8.62%
SpS24.47
BVpS18.92
TBVpS17.86
PEG (NY)N/A
PEG (5Y)0.29
Graham Number39.63
Profitability
Industry RankSector Rank
ROA 1.49%
ROE 8.39%
ROCE 3.06%
ROIC 2.63%
ROICexc 2.75%
ROICexgc 3.74%
OM 13.29%
PM (TTM) 6.49%
GM N/A
FCFM 7.45%
ROA(3y)2.52%
ROA(5y)0.87%
ROE(3y)13.51%
ROE(5y)4.58%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5Y0.56%
PM growth 3YN/A
PM growth 5Y-2.86%
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.23
Health
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF 3.21
Debt/EBITDA 1.74
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 250
Cash Conversion 54.38%
Profit Quality 114.77%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score6
WACC8.92%
ROIC/WACC0.29
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)284.38%
EPS 3YN/A
EPS 5Y19.73%
EPS Q2Q%1615.38%
EPS Next Y-33.11%
EPS Next 2Y-13.85%
EPS Next 3Y-5.53%
EPS Next 5YN/A
Revenue 1Y (TTM)14.72%
Revenue growth 3Y15.03%
Revenue growth 5Y29.21%
Sales Q2Q%8.91%
Revenue Next Year6.95%
Revenue Next 2Y6.64%
Revenue Next 3Y10.43%
Revenue Next 5YN/A
EBIT growth 1Y-22.34%
EBIT growth 3YN/A
EBIT growth 5Y29.93%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y18.02%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y18.02%
OCF growth 3YN/A
OCF growth 5YN/A

SIRIUSPOINT LTD / SPNT FAQ

What is the fundamental rating for SPNT stock?

ChartMill assigns a fundamental rating of 3 / 10 to SPNT.


What is the valuation status for SPNT stock?

ChartMill assigns a valuation rating of 5 / 10 to SIRIUSPOINT LTD (SPNT). This can be considered as Fairly Valued.


Can you provide the profitability details for SIRIUSPOINT LTD?

SIRIUSPOINT LTD (SPNT) has a profitability rating of 3 / 10.


How financially healthy is SIRIUSPOINT LTD?

The financial health rating of SIRIUSPOINT LTD (SPNT) is 2 / 10.


What is the earnings growth outlook for SIRIUSPOINT LTD?

The Earnings per Share (EPS) of SIRIUSPOINT LTD (SPNT) is expected to decline by -33.11% in the next year.